Xtant Medical Holdings Inc. (XTNT)
XTNT trades on NYSE in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$0.3243
-1.43% on the day
Market cap
$45.5M
Nano cap
Revenue · 2025
$133.9M
+14.2% on 2024
Net income · 2025
$5K
0.0% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | XTNT on NYSE |
| Sector | Health Care |
| Industry | Medical/Dental Instruments |
| Country | United States |
| IPO year | Not reported by the screener |
| SEC CIK | 0001453593 |
| SEC industry code | Surgical & Medical Instruments & Apparatus |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $133.9M |
| Net income | $5K |
| Operating income | $7.3M |
| Net margin | 0.0% |
| Operating margin | 5.4% |
| Revenue growth | +14.2% |
| Cash | $17.1M |
| Total assets | $94.1M |
| P/E (computed) | 9148.5× |
| P/S (computed) | 0.3× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B3 | 2025-05-20 |
| Latest annual report | 10-K | 2026-03-31 |
| Latest quarterly / interim | 10-Q | 2026-08-11 |
| Latest current report | 8-K | 2026-08-11 |
| Latest proxy | DEFA14A | 2026-06-23 |
Source: SEC EDGAR submissions feed, 1,000 recent filings. All filings on EDGAR.
Peers in Medical/Dental Instruments
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| SRTS | Sensus Healthcare Inc. | $2.89 | -1.36% | $47.6M |
| TELA | TELA Bio Inc. | $1.06 | -1.39% | $48.1M |
| SNWV | SANUWAVE Health Inc. | $5.61 | -3.94% | $48.3M |
| MDAI | Spectral AI Inc. | $1.56 | -2.50% | $50.2M |
| NEPH | Nephros Inc. | $3.59 | +0.56% | $39.0M |
| GUTS | Fractyl Health Inc. | $4.03 | -8.73% | $53.4M |
| DRIO | DarioHealth Corp. | $5.54 | +2.21% | $54.3M |
| AXNX | Axonex AI Group Limited | $0.7100 | Not reported | $36.3M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier